The immune inhibitory receptor leukocyte immunoglobulin like receptor B1 (LILRB1), which is upregulated and activated by human leukocyte antigen-G (HLA-G), drives natural killer (NK) cell exhaustion in tuberculosis (TB) patients, thus serving as a promising target for TB immunotherapy. The gene discussed is LILRB1; the disease is tuberculosis.